**Author details**

Rosario Perona1,2,3\*, Laura Iarriccio1,4, Laura Pintado-Berninches1,4, Javier Rodriguez-Centeno1,4, Cristina Manguan-Garcia1,2, Elena Garcia4 , Blanca Lopez-Ayllón1,3 and Leandro Sastre1,2,3


## **References**


[19] Giardini MA, Segatto M, da Silva MS, Nunes VS, Cano MI. Telomere and telomerase biology. Prog Mol Biol Transl Sci. 2014;125:1-40.

[4] Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fi‐

[5] Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med. 2006 Oct;12(10):

[6] Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase

[7] Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific as‐ sociation of human telomerase activity with immortal cells and cancer. Science. 1994

[8] Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in hu‐ man germline and embryonic tissues and cells. Dev Genet. 1996;18(2):173-9.

[9] Armanios M. Telomeres and age-related disease: how telomere biology informs clini‐

[10] Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of ag‐

[11] Nabetani A, Ishikawa F. Alternative lengthening of telomeres pathway: recombina‐ tion-mediated telomere maintenance mechanism in human cells. J Biochem. 2010 Jan;

[12] Savage SA. Human telomeres and telomere biology disorders. Prog Mol Biol Transl

[13] Stanley SE, Armanios M. The short and long telomere syndromes: paired paradigms

[14] Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, et al. TERT promoter mutations in familial and sporadic melanoma. Science. 2013 Feb 22;339(6122):959-61.

[15] Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013 Feb 22;339(6122):957-9.

[16] Aoude LG, Pritchard AL, Robles-Espinoza CD, Wadt K, Harland M, Choi J, et al. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial

[17] Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Dodda‐ paneni H, et al. Germline mutations in shelterin complex genes are associated with

[18] Bertuch AA. The Molecular Genetics of the Telomere Biology Disorders. RNA Biol.

for molecular medicine. Curr Opin Genet Dev. 2015 Aug;33:1-9.

melanoma. J Natl Cancer Inst. 2015 Feb;107(2):pli:dju408.

familial glioma. J Natl Cancer Inst. 2015 Jan;107(1):384.

activity in Tetrahymena extracts. Cell. 1985 Dec;43(2 Pt 1):405-13.

cal paradigms. J Clin Invest. 2013 Mar;123(3):996-1002.

ing. Cell. 2013 Jun 6;153(6):1194-217.

broblasts. Nature. 1990 May 31;345(6274):458-60.

1133-8.

102 Telomere - A Complex End of a Chromosome

149(1):5-14.

Sci. 2014;125:41-66.

2016; 13(8):696-706.

Dec 23;266(5193):2011-5.


[48] Vannier JB, Pavicic-Kaltenbrunner V, Petalcorin MI, Ding H, Boulton SJ. RTEL1 dis‐ mantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell. 2012 May 11;149(4):795-806.

[33] Diotti R, Loayza D. Shelterin complex and associated factors at human telomeres.

[34] Nandakumar J, Cech TR. Finding the end: recruitment of telomerase to telomeres.

[35] Martinez P, Blasco MA. Replicating through telomeres: a means to an end. Trends Bi‐

[36] Schmidt JC, Cech TR. Human telomerase: biogenesis, trafficking, recruitment, and

[37] Watson JD. Origin of concatemeric T7 DNA. Nat New Biol. 1972 Oct 18;239(94):

[38] Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telo‐ merase required for telomere repeat synthesis. Nature. 1989 Jan 26;337(6205):331-7.

[39] Mitchell JR, Cheng J, Collins K. A box H/ACA small nucleolar RNA-like domain at

[40] Berndt H, Harnisch C, Rammelt C, Stohr N, Zirkel A, Dohm JC, et al. Maturation of mammalian H/ACA box snoRNAs: PAPD5-dependent adenylation and PARN-de‐

[41] Moon DH, Segal M, Boyraz B, Guinan E, Hofmann I, Cahan P, et al. Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.

[42] Angrisani A, Vicidomini R, Turano M, Furia M. Human dyskerin: beyond telomeres.

[43] Egan ED, Collins K. Specificity and stoichiometry of subunit interactions in the hu‐ man telomerase holoenzyme assembled in vivo. Mol Cell Biol. 2010 Jun;30(11):

[44] Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD, et al. A hu‐ man telomerase holoenzyme protein required for Cajal body localization and telo‐

[45] Zhong FL, Batista LF, Freund A, Pech MF, Venteicher AS, Artandi SE. TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome

[46] Nandakumar J, Bell CF, Weidenfeld I, Zaug AJ, Leinwand LA, Cech TR. The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.

[47] Williamson JR, Raghuraman MK, Cech TR. Monovalent cation-induced structure of

telomeric DNA: the G-quartet model. Cell. 1989 Dec 1;59(5):871-80.

the human telomerase RNA 3' end. Mol Cell Biol. 1999 Jan;19(1):567-76.

Nucleus. 2011 Mar-Apr;2(2):119-35.

104 Telomere - A Complex End of a Chromosome

ochem Sci. 2015 Sep;40(9):504-15.

197-201.

2775-86.

Nat Rev Mol Cell Biol. 2013 Feb;14(2):69-82.

activation. Genes Dev. 2015 Jun 1;29(11):1095-105.

pendent trimming. RNA. 2012 May;18(5):958-72.

mere synthesis. Science. 2009 Jan 30;323(5914):644-8.

Nat Genet. 2015 Dec;47(12):1482-8.

Biol Chem. 2014 Jun;395(6):593-610.

ends. Cell. 2012 Aug 3;150(3):481-94.

Nature. 2012 Dec 13;492(7428):285-9.


[76] Aubert G, Hills M, Lansdorp PM. Telomere length measurement-caveats and a criti‐ cal assessment of the available technologies and tools. Mutat Res. 2012 Feb 1;730(1-2): 59-67.

[63] Pignolo RJ, Suda RK, McMillan EA, Shen J, Lee SH, Choi Y, et al. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis.

[64] Dokal I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program.

[65] Calado RT, Regal JA, Kleiner DE, Schrump DS, Peterson NR, Pons V, et al. A spec‐ trum of severe familial liver disorders associate with telomerase mutations. PLoS

[66] Rackley S, Pao M, Seratti GF, Giri N, Rasimas JJ, Alter BP, et al. Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biolo‐

[67] Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood.

[68] Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dys‐ keratosis congenita: their impact on telomere length and the diversity of clinical pre‐

[69] Knight SW, Heiss NS, Vulliamy TJ, Greschner S, Stavrides G, Pai GS, et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1

[70] Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human

[71] Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis con‐

[72] Alder JK, Barkauskas CE, Limjunyawong N, Stanley SE, Kembou F, Tuder RM, et al. Telomere dysfunction causes alveolar stem cell failure. Proc Natl Acad Sci U S A.

[73] Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis con‐

[74] Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, et al. Hap‐ loinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):

[75] Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology

disease dyskeratosis congenita. Nature. 1999 Dec 2;402(6761):551-5.

genita due to mutations in TERC. Nat Genet. 2004 May;36(5):447-9.

Aging Cell. 2008 Jan;7(1):23-31.

gy? Psychosomatics. 2012 May-Jun;53(3):230-5.

sentation. Blood. 2006 Apr 1;107(7):2680-5.

gene. Am J Hum Genet. 1999 Jul;65(1):50-8.

genita. Nature. 2001 Sep 27;413(6854):432-5.

disorders. Genet Med. 2010 Dec;12(12):753-64.

2015 Apr 21;112(16):5099-104.

15960-4.

2011;2011:480-6.

106 Telomere - A Complex End of a Chromosome

One. 2009;4(11):e7926.

2009 Jun 25;113(26):6549-57.


[102] Xin ZT, Beauchamp AD, Calado RT, Bradford JW, Regal JA, Shenoy A, et al. Func‐ tional characterization of natural telomerase mutations found in patients with hema‐ tologic disorders. Blood. 2007 Jan 15;109(2):524-32.

[89] Tycowski KT, Shu MD, Kukoyi A, Steitz JA. A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles. Mol Cell. 2009 Apr 10;34(1):47-57.

[90] Wong JM, Collins K. Telomerase RNA level limits telomere maintenance in X-linked

[91] Carrillo J, Gonzalez A, Manguan-Garcia C, Pintado-Berninches L, Perona R. p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage. Clin

[92] Bellodi C, Kopmar N, Ruggero D. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J. 2010 Jun

[93] Walbott H, Machado-Pinilla R, Liger D, Blaud M, Rety S, Grozdanov PN, et al. The H/ACA RNP assembly factor SHQ1 functions as an RNA mimic. Genes Dev. 2011

[94] Grozdanov PN, Fernandez-Fuentes N, Fiser A, Meier UT. Pathogenic NAP57 muta‐ tions decrease ribonucleoprotein assembly in dyskeratosis congenita. Hum Mol Gen‐

[95] Brault ME, Lauzon C, Autexier C. Dyskeratosis congenita mutations in dyskerin SU‐ MOylation consensus sites lead to impaired telomerase RNA accumulation and telo‐

[96] Salowsky R, Heiss NS, Benner A, Wittig R, Poustka A. Basal transcription activity of the dyskeratosis congenita gene is mediated by Sp1 and Sp3 and a patient mutation in a Sp1 binding site is associated with decreased promoter activity. Gene. 2002 Jun

[97] Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR. Reverse tran‐ scriptase motifs in the catalytic subunit of telomerase. Science. 1997 Apr 25;276(5312):

[98] Moriarty TJ, Ward RJ, Taboski MA, Autexier C. An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.

[99] Bryan TM, Goodrich KJ, Cech TR. Telomerase RNA bound by protein motifs specific

[100] Podlevsky JD, Bley CJ, Omana RV, Qi X, Chen JJ. The telomerase database. Nucleic

[101] Collopy LC, Walne AJ, Cardoso S, de la Fuente J, Mohamed M, Toriello H, et al. Tri‐ allelic and epigenetic-like inheritance in human disorders of telomerase. Blood. 2015

to telomerase reverse transcriptase. Mol Cell. 2000 Aug;6(2):493-9.

mere defects. Hum Mol Genet. 2013 Sep 1;22(17):3498-507.

dyskeratosis congenita. Genes Dev. 2006 Oct 15;20(20):2848-58.

Transl Oncol. 2013 Jun;16(6):529-38.

2;29(11):1865-76.

108 Telomere - A Complex End of a Chromosome

26;293(1-2):9-19.

Jul 9;126(2):176-84.

561-7.

Nov 15;25(22):2398-408.

et. 2009 Dec 1;18(23):4546-51.

Mol Biol Cell. 2005 Jul;16(7):3152-61.

Acids Res. 2008 Jan;36(Database issue):D339-43.


[128] Stuart BD, Choi J, Zaidi S, Xing C, Holohan B, Chen R, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere short‐ ening. Nat Genet. 2015 May;47(5):512-7.

[115] Frescas D, de Lange T. A TIN2 dyskeratosis congenita mutation causes telomeraseindependent telomere shortening in mice. Genes Dev. 2014 Jan 15;28(2):153-66. [116] Henriksson S, Farnebo M. On the road with WRAP53beta: guardian of Cajal bodies

[117] Stern JL, Zyner KG, Pickett HA, Cohen SB, Bryan TM. Telomerase recruitment re‐ quires both TCAB1 and Cajal bodies independently. Mol Cell Biol. 2012 Jul;32(13):

[118] Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, et al. Disruption of telo‐ merase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev.

[119] Trahan C, Martel C, Dragon F. Effects of dyskeratosis congenita mutations in dysker‐ in, NHP2 and NOP10 on assembly of H/ACA pre-RNPs. Hum Mol Genet. 2009 Mar

[120] Vulliamy T, Beswick R, Kirwan M, Marrone A, Digweed M, Walne A, et al. Muta‐ tions in the telomerase component NHP2 cause the premature ageing syndrome dys‐

[121] Keller RB, Gagne KE, Usmani GN, Asdourian GK, Williams DA, Hofmann I, et al. CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer. 2012

[122] Walne AJ, Bhagat T, Kirwan M, Gitiaux C, Desguerre I, Leonard N, et al. Mutations in the telomere capping complex in bone marrow failure and related syndromes.

[123] Chen LY, Majerska J, Lingner J. Molecular basis of telomere syndrome caused by

[124] White MF. Structure, function and evolution of the XPD family of iron-sulfur-con‐ taining 5'-->3' DNA helicases. Biochem Soc Trans. 2009 Jun;37(Pt 3):547-51.

[125] Uringa EJ, Lisaingo K, Pickett HA, Brind'Amour J, Rohde JH, Zelensky A, et al. RTEL1 contributes to DNA replication and repair and telomere maintenance. Mol Bi‐

[126] Ballew BJ, Yeager M, Jacobs K, Giri N, Boland J, Burdett L, et al. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.

[127] Le Guen T, Jullien L, Touzot F, Schertzer M, Gaillard L, Perderiset M, et al. Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and

genome instability. Hum Mol Genet. 2013 Aug 15;22(16):3239-49.

keratosis congenita. Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8073-8.

and genome integrity. Front Genet. 2015;6:91.

2384-95.

110 Telomere - A Complex End of a Chromosome

2011 Jan 1;25(1):11-6.

1;19(5):825-36.

Aug;59(2):311-4.

Haematologica. 2013 Mar;98(3):334-8.

ol Cell. 2012 Jul;23(14):2782-92.

Hum Genet. 2013 Apr;132(4):473-80.

CTC1 mutations. Genes Dev. 2013 Oct 1;27(19):2099-108.


[153] Revesz T, Fletcher S, al-Gazali LI, DeBuse P. Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? J Med Genet. 1992 Sep; 29(9):673-5.

[141] Malbora B, Avci Z, Ozbek N. Aplastic anemia and Hoyeraal-Hreidarsson syndrome.

[142] Ballew BJ, Joseph V, De S, Sarek G, Vannier JB, Stracker T, et al. A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe im‐ munodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet. 2013

[143] Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P, et al. Unex‐ plained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1.

[144] Lai W, Deng WP, Liu X, Chen HM, Dai Sh X. A recurrent p. A353V mutation in DKC1 responsible for different phenotypes of dyskeratosis congenita in a Chinese

[145] Marrone A, Sokhal P, Walne A, Beswick R, Kirwan M, Killick S, et al. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica. 2007 Aug;92(8):1013-20. [146] Gramatges MM, Qi X, Sasa GS, Chen JJ, Bertuch AA. A homozygous telomerase Tmotif variant resulting in markedly reduced repeat addition processivity in siblings

with Hoyeraal Hreidarsson syndrome. Blood. 2013 May 2;121(18):3586-93.

[147] Vogiatzi P, Perdigones N, Mason PJ, Wilson DB, Bessler M. A family with Hoyeraal-Hreidarsson syndrome and four variants in two genes of the telomerase core com‐

[148] Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone mar‐

[149] Ye JZ, Hockemeyer D, Krutchinsky AN, Loayza D, Hooper SM, Chait BT, et al. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the

[150] Takai KK, Kibe T, Donigian JR, Frescas D, de Lange T. Telomere protection by TPP1/

[151] Kocak H, Ballew BJ, Bisht K, Eggebeen R, Hicks BD, Suman S, et al. Hoyeraal-Hrei‐ darsson syndrome caused by a germline mutation in the TEL patch of the telomere

[152] Guo Y, Kartawinata M, Li J, Pickett HA, Teo J, Kilo T, et al. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere pro‐

POT1 requires tethering to TIN2. Mol Cell. 2011 Nov 18;44(4):647-59.

Skinmed. 2014 Mar-Apr;12(2):117-8.

Br J Haematol. 1999 Nov;107(2):335-9.

family. J Dermatol Sci. 2011 Aug;63(2):122-4.

plex. Pediatr Blood Cancer. 2013 Jun;60(6):E4-6.

row failure. Blood Cells Mol Dis. 2005 May-Jun;34(3):257-63.

TIN2/TRF1 complex. Genes Dev. 2004 Jul 15;18(14):1649-54.

protein TPP1. Genes Dev. 2014 Oct 1;28(19):2090-102.

tein TPP1. Blood. 2014 Oct 30;124(18):2767-74.

Aug;9(8):e1003695.

112 Telomere - A Complex End of a Chromosome


[178] Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood. 2009 Sep 10;114(11):2236-43.

[166] Cogan JD, Kropski JA, Zhao M, Mitchell DB, Rives L, Markin C, et al. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am J Respir Crit Care

[167] Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A. 2008 Sep

[168] Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet.

[169] Kropski JA, Mitchell DB, Markin C, Polosukhin VV, Choi L, Johnson JE, et al. A nov‐ el dyskerin (DKC1) mutation is associated with familial interstitial pneumonia.

[170] Fukuhara A, Tanino Y, Ishii T, Inokoshi Y, Saito K, Fukuhara N, et al. Pulmonary fib‐ rosis in dyskeratosis congenita with TINF2 gene mutation. Eur Respir J. 2013 Dec;

[171] Stanley SE, Chen JJ, Podlevsky JD, Alder JK, Hansel NN, Mathias RA, et al. Telomer‐ ase mutations in smokers with severe emphysema. J Clin Invest. 2015 Feb;125(2):

[172] Parry EM, Alder JK, Qi X, Chen JJ, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011

[173] Calado RT, Brudno J, Mehta P, Kovacs JJ, Wu C, Zago MA, et al. Constitutional telo‐ merase mutations are genetic risk factors for cirrhosis. Hepatology. 2011 May;53(5):

[174] Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia

due to mutations in telomerase RNA. Lancet. 2003 Nov 15;362(9396):1628-30.

nita. Biol Blood Marrow Transplant. 2013 Aug;19(8):1238-43.

[175] Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, et al. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis conge‐

[176] Ayas M, Nassar A, Hamidieh AA, Kharfan-Dabaja M, Othman TB, Elhaddad A, et al. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. Bone Marrow Transplant. 2013 Sep;48(9):1168-72. [177] Islam A, Rafiq S, Kirwan M, Walne A, Cavenagh J, Vulliamy T, et al. Haematological recovery in dyskeratosis congenita patients treated with danazol. Br J Haematol. 2013

Med. 2015 Mar 15;191(6):646-55.

2;105(35):13051-6.

114 Telomere - A Complex End of a Chromosome

Chest. 2014 Jul;146(1):e1-7.

May 26;117(21):5607-11.

2009;10:45-61.

42(6):1757-9.

563-70.

1600-7.

Sep;162(6):854-6.


[202] Egusquiaguirre SP, Manguan-Garcia C, Pintado-Berninches L, Iarriccio L, Carbajo D, Albericio F, et al. Development of surface modified biodegradable polymeric nano‐ particles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders. Eur J Pharm Biopharm. 2015 Apr;91:91-102.

[190] Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, Blasco MA. Disease states associated with telomerase deficiency appear earlier in mice with short telo‐

[191] Gu BW, Bessler M, Mason PJ. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc

[192] Beier F, Foronda M, Martinez P, Blasco MA. Conditional TRF1 knockout in the hema‐ topoietic compartment leads to bone marrow failure and recapitulates clinical fea‐

[193] Simeonova I, Jaber S, Draskovic I, Bardot B, Fang M, Bouarich-Bourimi R, et al. Mu‐ tant mice lacking the p53 C-terminal domain model telomere syndromes. Cell Rep.

[194] Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM, et al. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and

[195] Ramunas J, Yakubov E, Brady JJ, Corbel SY, Holbrook C, Brandt M, et al. Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human

[196] Maida Y, Masutomi K. Telomerase reverse transcriptase moonlights: Therapeutic tar‐

[197] Gu BW, Fan JM, Bessler M, Mason PJ. Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment. Aging

[198] Machado-Pinilla R, Sanchez-Perez I, Murguia JR, Sastre L, Perona R. A dyskerin mo‐ tif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomer‐

[199] Machado-Pinilla R, Carrillo J, Manguan-Garcia C, Sastre L, Mentzer A, Gu BW, et al. Defects in mTR stability and telomerase activity produced by the Dkc1 A353V muta‐ tion in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB do‐

[200] Manguan-Garcia C, Pintado-Berninches L, Carrillo J, Machado-Pinilla R, Sastre L, Perez-Quilis C, et al. Expression of the genetic suppressor element 24.2 (GSE24.2) de‐ creases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells.

[201] Iarriccio L, Manguan-Garcia C, Pintado-Berninches L, Mancheno JM, Molina A, Pero‐ na R, et al. GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomer‐ ase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell

Senescence in Dyskerin Mutant Cells. PLoS One. 2015;10(11):e0142980.

tures of dyskeratosis congenita. Blood. 2012 Oct 11;120(15):2990-3000.

meres. EMBO J. 1999 Jun 1;18(11):2950-60.

2013 Jun 27;3(6):2046-58.

116 Telomere - A Complex End of a Chromosome

Natl Acad Sci U S A. 2008 Jul 22;105(29):10173-8.

age normally. EMBO J. 2002 Nov 15;21(22):6225-35.

gets beyond telomerase. Cancer Sci. 2015 106(11):1486-92.

ase-deficient human cells. Blood. 2008 Mar 1;111(5):2606-14.

main. Clin Transl Oncol. 2012 Oct;14(10):755-63.

cells. FASEB J. 2015 May;29(5):1930-9.

Cell. 2011 Apr;10(2):338-48.

PLoS One. 2014;9(7):e101424.
